{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:51:08Z","timestamp":1793317868612,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.omtn.2023.102111","type":"journal-article","created":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T11:37:27Z","timestamp":1703590647000},"page":"102111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["AAV-based gene editing of type 1 collagen mutation to treat osteogenesis imperfecta"],"prefix":"10.1016","volume":"35","author":[{"given":"Yeon-Suk","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadatoshi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Chaugule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hyuck","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2023.102111_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11914-007-0023-z","article-title":"Osteogenesis imperfecta:epidemiology and pathophysiology","volume":"5","author":"Martin","year":"2007","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.omtn.2023.102111_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.52","article-title":"Osteogenesis imperfecta","volume":"3","author":"Marini","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.omtn.2023.102111_bib3","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/MOP.0000000000000813","article-title":"Osteogenesis imperfecta: advancements in genetics and treatment","volume":"31","author":"Rossi","year":"2019","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.omtn.2023.102111_bib4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/MED.0000000000000367","article-title":"Osteogenesis imperfecta: diagnosis and treatment","volume":"24","author":"Palomo","year":"2017","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.omtn.2023.102111_bib5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/ejhg.2013.198","article-title":"Allele-specific Col1a1 silencing reduces mutant collagen in fibroblasts from Brtl mouse, a model for classical osteogenesis imperfecta","volume":"22","author":"Rousseau","year":"2014","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2023.102111_bib6","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.7150\/ijms.5774","article-title":"Allele dependent silencing of collagen type I using small interfering RNAs targeting 3'UTR Indels - a novel therapeutic approach in osteogenesis imperfecta","volume":"10","author":"Lindahl","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.omtn.2023.102111_bib7","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2023.102111_bib8","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/mt.2011.287","article-title":"The AAV vector toolkit: poised at the clinical crossroads","volume":"20","author":"Asokan","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2023.102111_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/gt.2008.170","article-title":"Tailoring the AAV vector capsid for gene therapy","volume":"16","author":"Vandenberghe","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2023.102111_bib10","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1038\/s41467-019-10809-6","article-title":"Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis","volume":"10","author":"Yang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2023.102111_bib11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ymthe.2022.09.018","article-title":"WNT-modulating gene silencers as a gene therapy for osteoporosis, bone fracture, and critical-sized bone defects","volume":"31","author":"Oh","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2023.102111_bib12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtn.2023.102111_bib13","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtn.2023.102111_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nbt.2842","article-title":"CRISPR-Cas systems for editing, regulating and targeting genomes","volume":"32","author":"Sander","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2023.102111_bib15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/gt.2016.72","article-title":"Non-viral delivery of genome-editing nucleases for gene therapy","volume":"24","author":"Wang","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2023.102111_bib16","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020401118","article-title":"Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in\u00a0vivo genome editing of Angptl3","volume":"118","author":"Qiu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2023.102111_bib17","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature13864","article-title":"Promoterless gene targeting without nucleases ameliorates haemophilia B in mice","volume":"517","author":"Barzel","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2023.102111_bib18","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/biot.201400046","article-title":"CRISPR\/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox","volume":"9","author":"Sen\u00eds","year":"2014","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.omtn.2023.102111_bib19","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nbt.4219","article-title":"Cas9-mediated allelic exchange repairs compound heterozygous recessive mutations in mice","volume":"36","author":"Wang","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2023.102111_bib20","article-title":"Muscle-specific CRISPR\/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy","volume":"8","author":"Bengtsson","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2023.102111_bib21","doi-asserted-by":"crossref","first-page":"12941","DOI":"10.1016\/S0021-9258(18)90635-6","article-title":"Osteogenesis imperfecta: cloning of a pro-alpha 2(I) collagen gene with a frameshift mutation","volume":"259","author":"Pihlajaniemi","year":"1984","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2023.102111_bib22","doi-asserted-by":"crossref","first-page":"16061","DOI":"10.1074\/jbc.M801982200","article-title":"Defective C-propeptides of the proalpha2(I) chain of type I procollagen impede molecular assembly and result in osteogenesis imperfecta","volume":"283","author":"Pace","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2023.102111_bib23","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1073\/pnas.90.5.1701","article-title":"Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta","volume":"90","author":"Chipman","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2023.102111_bib24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/jmg.21.4.257","article-title":"The clinical features of homozygous alpha 2(I) collagen deficient osteogenesis imperfecta","volume":"21","author":"Nicholls","year":"1984","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.omtn.2023.102111_bib25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In\u00a0vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2023.102111_bib26","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/stem.1107","article-title":"Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy","volume":"30","author":"Gioia","year":"2012","journal-title":"Stem Cell."},{"key":"10.1016\/j.omtn.2023.102111_bib27","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2023.102111_bib28","first-page":"277","article-title":"[a New Method for the Measurement of Muscle Relaxation in White Mice]","volume":"152","author":"Kondziella","year":"1964","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.omtn.2023.102111_bib29","first-page":"2610","article-title":"Measuring the strength of mice","volume":"76","author":"Deacon","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.omtn.2023.102111_bib30","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2023.102111_bib31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2023.102111_bib32","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","article-title":"Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system","volume":"163","author":"Zetsche","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2023.102111_bib33","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2023.102111_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ydbio.2014.06.017","article-title":"Somatic mosaicism and allele complexity induced by CRISPR\/Cas9 RNA injections in mouse zygotes","volume":"393","author":"Yen","year":"2014","journal-title":"Dev. Biol."},{"key":"10.1016\/j.omtn.2023.102111_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/srep42081","article-title":"Promoting Cas9 degradation reduces mosaic mutations in non-human primate embryos","volume":"7","author":"Tu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2023.102111_bib36","article-title":"Coupling AAV-mediated promoterless gene targeting to SaCas9 nuclease to efficiently correct liver metabolic diseases","volume":"5","author":"De Caneva","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtn.2023.102111_bib37","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nmeth.1903","article-title":"Long-term, efficient inhibition of microRNA function in mice using rAAV vectors","volume":"9","author":"Xie","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2023.102111_bib38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bonr.2018.06.008","article-title":"Loss of RANKL in osteocytes dramatically increases cancellous bone mass in the osteogenesis imperfecta mouse (oim)","volume":"9","author":"Zimmerman","year":"2018","journal-title":"Bone Rep."},{"key":"10.1016\/j.omtn.2023.102111_bib39","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.omtm.2020.04.010","article-title":"Bone-Targeting AAV-Mediated Gene Silencing in Osteoclasts for Osteoporosis Therapy","volume":"17","author":"Yang","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253123003293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253123003293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:42:31Z","timestamp":1760856151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253123003293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2162253123003293"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2023.102111","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV-based gene editing of type 1 collagen mutation to treat osteogenesis imperfecta","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2023.102111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"102111"}}